• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于黏液穿透丝素纳米治疗溃疡性结肠炎的高效疗法。

Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.

State Key Laboratory of Silkworm Genome Biology, College of Sericulture, Textile, and Biomass Sciences, Southwest University, Chongqing 400715, China.

出版信息

Biomolecules. 2022 Sep 8;12(9):1263. doi: 10.3390/biom12091263.

DOI:10.3390/biom12091263
PMID:36139101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9496219/
Abstract

Oral nanoparticles have been considered a prospective drug delivery carrier against ulcerative colitis (UC). To enhance the mucus-penetrating capacity and aqueous solubility, and strengthen the anti-inflammatory effect of resveratrol (RSV), we fabricated RSV-loaded silk fibroin-based nanoparticles with the functionalization of Pluronic F127 (PF-127). The obtained PF-127-functionalized RSV-loaded NPs had an average particle size around 170 nm, a narrow size distribution (polydispersity index < 0.2), and negative zeta potential (−20.5 mV). Our results indicated that the introduction of PF-127 strengthened the mucus-penetrating property of NPs. In vitro studies suggested that NPs with PF-127 enhanced the suppression of the secretion of proinflammatory cytokine TNF-α and reactive oxygen species (ROS) from RAW 264.7 macrophages under lipopolysaccharide stimulation in comparison with other counterparts. According to the evaluation of macro symptoms and main inflammatory cytokines, we further report preferable therapeutic outcomes achieved by PF-127 functionalized-NP-treated dextran sulphate sodium (DSS) groups in the colitis model compared with blank silk fibroin NPs and RSV-loaded NPs without the functionalization of PF-127. Taken together, this work suggests that the fabricated PF-127 NPs via the oral route are promising and useful RSV-loaded nanocarriers for UC treatment.

摘要

口服纳米颗粒被认为是一种有前途的药物输送载体,可用于治疗溃疡性结肠炎(UC)。为了增强纳米颗粒的穿透黏液能力和水溶解度,并增强白藜芦醇(RSV)的抗炎效果,我们用具有 PF-127 功能化的丝素蛋白制备了负载 RSV 的纳米颗粒。所得的 PF-127 功能化 RSV 负载 NPs 的平均粒径约为 170nm,粒径分布较窄(多分散指数 < 0.2),且具有负的 zeta 电位(-20.5mV)。我们的结果表明,PF-127 的引入增强了 NPs 的穿透黏液性能。体外研究表明,与其他对照物相比,PF-127 增强了 NPs 对脂多糖刺激下 RAW264.7 巨噬细胞分泌促炎细胞因子 TNF-α和活性氧(ROS)的抑制作用。根据宏观症状和主要炎症细胞因子的评估,我们进一步报告了在结肠炎模型中,与空白丝素蛋白 NPs 和未用 PF-127 功能化的 RSV 负载 NPs 相比,PF-127 功能化-NP 处理的葡聚糖硫酸钠(DSS)组取得了更好的治疗效果。综上所述,该工作表明,通过口服途径制备的 PF-127 NPs 是一种有前途的、用于 UC 治疗的负载 RSV 的纳米载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/eca3bf7b1f09/biomolecules-12-01263-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/6bc3da0bbf04/biomolecules-12-01263-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/adb1747eac99/biomolecules-12-01263-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/b573ebc4bafa/biomolecules-12-01263-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/85dccee4e150/biomolecules-12-01263-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/832a43eb2c79/biomolecules-12-01263-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/d0672dda823a/biomolecules-12-01263-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/eca3bf7b1f09/biomolecules-12-01263-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/6bc3da0bbf04/biomolecules-12-01263-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/adb1747eac99/biomolecules-12-01263-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/b573ebc4bafa/biomolecules-12-01263-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/85dccee4e150/biomolecules-12-01263-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/832a43eb2c79/biomolecules-12-01263-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/d0672dda823a/biomolecules-12-01263-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ff/9496219/eca3bf7b1f09/biomolecules-12-01263-g007.jpg

相似文献

1
Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis.基于黏液穿透丝素纳米治疗溃疡性结肠炎的高效疗法。
Biomolecules. 2022 Sep 8;12(9):1263. doi: 10.3390/biom12091263.
2
Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.具有按需细胞质药物释放能力的多生物响应丝素基纳米粒子,用于 CD44 靶向缓解溃疡性结肠炎。
Biomaterials. 2019 Aug;212:39-54. doi: 10.1016/j.biomaterials.2019.05.012. Epub 2019 May 9.
3
Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.用于将姜黄素递送至结肠炎组织的增强黏液穿透性和 ROS 响应性药物释放能力的口服纳米治疗剂。
J Mater Chem B. 2021 Feb 14;9(6):1604-1615. doi: 10.1039/d0tb02092c. Epub 2021 Jan 20.
4
Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.溃疡性结肠炎治疗中结肠炎组织蓄积多孔纳米粒子的口服给药。
Int J Pharm. 2019 Feb 25;557:135-144. doi: 10.1016/j.ijpharm.2018.12.046. Epub 2018 Dec 27.
5
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.通过透明质酸功能化纳米颗粒口服靶向递送三肽KPV可有效缓解溃疡性结肠炎。
Mol Ther. 2017 Jul 5;25(7):1628-1640. doi: 10.1016/j.ymthe.2016.11.020. Epub 2017 Jan 28.
6
Oral nanotherapeutics based on Antheraea pernyi silk fibroin for synergistic treatment of ulcerative colitis.基于野蚕丝素蛋白的口服纳米治疗剂协同治疗溃疡性结肠炎。
Biomaterials. 2022 Mar;282:121410. doi: 10.1016/j.biomaterials.2022.121410. Epub 2022 Feb 16.
7
Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.盐酸小檗碱载黏液穿透性海藻酸钠-壳聚糖纳米粒口服递送至溃疡性结肠炎炎症部位。
AAPS PharmSciTech. 2022 Jun 27;23(6):179. doi: 10.1208/s12249-022-02327-4.
8
Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.粒径对口服纳米治疗药物细胞摄取和抗炎活性的影响。
Colloids Surf B Biointerfaces. 2020 Mar;187:110880. doi: 10.1016/j.colsurfb.2020.110880. Epub 2020 Feb 18.
9
Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment.通过羧甲基壳聚糖修饰的纳米颗粒经口递送虾青素治疗溃疡性结肠炎。
Molecules. 2024 Mar 14;29(6):1291. doi: 10.3390/molecules29061291.
10
cRGD peptide incorporated with patchouli alcohol loaded silk fibroin nanoparticles for enhanced targeting of inflammatory sites in colitis.载姜烯醇的丝素蛋白纳米粒载 cRGD 肽增强结肠炎炎症部位靶向治疗
Biomater Adv. 2022 Sep;140:213069. doi: 10.1016/j.bioadv.2022.213069. Epub 2022 Aug 6.

引用本文的文献

1
Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems.基于蛋白质的纳米颗粒药物递送系统在炎症性肠病口服治疗中的进展。
Drug Deliv. 2025 Dec;32(1):2544689. doi: 10.1080/10717544.2025.2544689. Epub 2025 Aug 11.
2
Immune Modulation with Oral DNA/RNA Nanoparticles.口服DNA/RNA纳米颗粒的免疫调节
Pharmaceutics. 2025 May 4;17(5):609. doi: 10.3390/pharmaceutics17050609.
3
Green synthesis of silver nanoparticles using cocoon extract of Bombyx mori L.: therapeutic potential in antibacterial, antioxidant, anti-inflammatory, and anti-tumor applications.

本文引用的文献

1
Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy.具有增强肿瘤穿透能力和氧气自生成能力的多响应纳米诊疗剂用于多模态协同癌症治疗。
Acta Pharm Sin B. 2022 Jan;12(1):406-423. doi: 10.1016/j.apsb.2021.07.001. Epub 2021 Jul 8.
2
'Green' nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases.茶叶来源的“绿色”纳米疗法,经口服靶向预防和缓解结肠疾病。
Biomaterials. 2021 Dec;279:121178. doi: 10.1016/j.biomaterials.2021.121178. Epub 2021 Oct 8.
3
Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases.
利用家蚕茧提取物绿色合成银纳米颗粒:在抗菌、抗氧化、抗炎和抗肿瘤应用中的治疗潜力。
BMC Biotechnol. 2025 May 14;25(1):38. doi: 10.1186/s12896-025-00971-9.
4
Compliant immune response of silk-based biomaterials broadens application in wound treatment.基于丝绸的生物材料的适应性免疫反应拓宽了其在伤口治疗中的应用。
Front Pharmacol. 2025 Feb 12;16:1548837. doi: 10.3389/fphar.2025.1548837. eCollection 2025.
5
Silk Protein Gene Engineering and Its Applications: Recent Advances in Biomedicine Driven by Molecular Biotechnology.丝蛋白基因工程及其应用:分子生物技术推动下生物医药领域的最新进展
Drug Des Devel Ther. 2025 Jan 25;19:599-626. doi: 10.2147/DDDT.S504783. eCollection 2025.
6
Overcoming Biopotency Barriers: Advanced Oral Delivery Strategies for Enhancing the Efficacy of Bioactive Food Ingredients.克服生物功效障碍:提高生物活性食品成分功效的先进口服递送策略。
Adv Sci (Weinh). 2024 Nov;11(44):e2401172. doi: 10.1002/advs.202401172. Epub 2024 Oct 3.
7
Alginate-Based Electrospun Nanofibers and the Enabled Drug Controlled Release Profiles: A Review.基于海藻酸盐的静电纺纳米纤维及其药物控制释放性能:综述。
Biomolecules. 2024 Jul 3;14(7):789. doi: 10.3390/biom14070789.
8
Hybrid films loaded with 5-fluorouracil and Reglan for synergistic treatment of colon cancer via asynchronous dual-drug delivery.负载5-氟尿嘧啶和胃复安的混合膜通过异步双药递送协同治疗结肠癌。
Front Bioeng Biotechnol. 2024 Jun 13;12:1398730. doi: 10.3389/fbioe.2024.1398730. eCollection 2024.
9
Electrospun Fenoprofen/Polycaprolactone @ Tranexamic Acid/Hydroxyapatite Nanofibers as Orthopedic Hemostasis Dressings.电纺非诺洛芬/聚己内酯@氨甲环酸/羟基磷灰石纳米纤维作为骨科止血敷料
Nanomaterials (Basel). 2024 Apr 8;14(7):646. doi: 10.3390/nano14070646.
10
A combined electrohydrodynamic atomization method for preparing nanofiber/microparticle hybrid medicines.一种用于制备纳米纤维/微粒混合药物的组合式电流体动力学雾化方法。
Front Bioeng Biotechnol. 2023 Nov 15;11:1308004. doi: 10.3389/fbioe.2023.1308004. eCollection 2023.
聚合物纳米粒经口服递呈天然活性小分子治疗炎症性肠病。
Adv Drug Deliv Rev. 2021 Sep;176:113887. doi: 10.1016/j.addr.2021.113887. Epub 2021 Jul 24.
4
Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer.四重响应纳米颗粒介导的转移性乳腺癌靶向联合化疗。
Nanoscale. 2021 Mar 21;13(11):5765-5779. doi: 10.1039/d0nr08579k. Epub 2021 Mar 11.
5
Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.用于将姜黄素递送至结肠炎组织的增强黏液穿透性和 ROS 响应性药物释放能力的口服纳米治疗剂。
J Mater Chem B. 2021 Feb 14;9(6):1604-1615. doi: 10.1039/d0tb02092c. Epub 2021 Jan 20.
6
Advanced Silk Fibroin Biomaterials for Cartilage Regeneration.用于软骨再生的先进丝素蛋白生物材料。
ACS Biomater Sci Eng. 2018 Aug 13;4(8):2704-2715. doi: 10.1021/acsbiomaterials.8b00150. Epub 2018 Jul 19.
7
Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics.肿瘤归巢型三重生物响应性纳米治疗剂抑制乳腺癌的生长和肺转移。
J Control Release. 2020 Dec 10;328:454-469. doi: 10.1016/j.jconrel.2020.08.066. Epub 2020 Sep 3.
8
Multi-responsive nanococktails with programmable targeting capacity for imaging-guided mitochondrial phototherapy combined with chemotherapy.具有可编程靶向能力的多重响应性纳米鸡尾酒,用于成像引导的线粒体光疗联合化疗。
J Control Release. 2020 Nov 10;327:371-383. doi: 10.1016/j.jconrel.2020.08.014. Epub 2020 Aug 15.
9
Silk fibroin scavenges hydroxyl radicals produced from a long-term stored water-soluble fullerene system.丝素蛋白清除长期储存的水溶性富勒烯体系产生的羟基自由基。
J Mater Chem B. 2018 Feb 7;6(5):769-780. doi: 10.1039/c7tb02774e. Epub 2018 Jan 19.
10
Silk fibroin-based nanotherapeutics: application in the treatment of colonic diseases.基于丝素蛋白的纳米治疗药物:在结肠疾病治疗中的应用。
Nanomedicine (Lond). 2019 Sep;14(17):2373-2378. doi: 10.2217/nnm-2019-0058. Epub 2019 Jul 10.